Blog

Read blog posts about our latest activities

Genome alignment tools: BWA-MEM or DRAGMAP?

Alignment involves the step when the short fragments of DNA sequence are being matched to the reference genome. For the workflows available on the IntelliseqFlow platform, we offer a choice of two alignment tools: BWA-MEM or DRAGMAP. While both tools are designed to perform the same task, they differ in their underlying algorithms and performance […]

Read more

Best practices for generating gene panels for NGS data analysis. The iFlow platform makes this feasible.

Workflows for Whole Genome Sequencing (WGS) and Whole Exome Sequencing (WES) data require specification of the genes to be analysed. This step is essential to perform a genomic analysis that will answer a specific question about the patient’s phenotype. We use the HPO database to identify gene candidates for analysis, which are later merged into […]

Read more

Intelliseq’s Key Takeaways from #ACMG23: The Future of Genomic Decision Making

This article features a post-ACMG event interview with Klaudia Szklarczyk-Smolana, the CEO of Intelliseq, and David Hanna, the Chief Commercial Officer at Intelliseq. They discuss their key takeaways from the event, the future of genomic clinical decision making, and Intelliseq’s plans to implement their learnings. The interview also highlights the importance of attending industry events […]

Read more

New functionality available in the hereditary disorders workflows!

We have added new functionality for report generation among NGS panel, WES and WGS hereditary disorders workflows (fastq input file). The Manual Filtering option allows new report generation with genes of choice, without the need to rerun the analysis. Each human genome differs on average in ~5 million positions from the reference. Therefore, the annotated […]

Read more

World Rare Diseases Day 2023

Rare Disease Day presented by: RareDiseaseDay is a global campaign to raise awareness about rare diseases and the importance of early and accurate diagnosis. Many rare diseases are genetic in nature, which means that genetic testing is an important tool in the diagnostic odyssey. Early and accurate diagnosis of rare diseases is crucial for improving […]

Read more

Whose genome is the reference genome?

In this text, we’ll take a closer look at the human reference genome – what is it and when do we need it in the context of Next-Generation Sequencing (NGS) data analysis. PRECISION AND SENSITIVITY OF NGS DATA ANALYSIS  The first step in the standard Next-Generation Sequencing data analysis is alignment. During this process, reads […]

Read more

World Rare Diseases Day Initiative

February 28th is World Rare Diseases Day. At Intelliseq, we have prepared an initiative supporting patient diagnostics. We realize that the diagnosis of genetic diseases is not easy in every case and often requires taking actions that go beyond standard activities. There is a great number of patients struggling with the diagnostic odyssey, waiting for […]

Read more

Exhibiting @PMWC 2022!

Attending Precision Medicine World Conference 2022!? Come and chat with us at booth #D2717 on June 28-30!  Learn more about PMWC here: https://www.pmwcintl.com/

Read more

IntelliseqFlow – new features available from early 2022

1) New workflows added We added new workflows covering more areas of genomic medicine: Somatic cancer workflows created with GATK best practices and ACMG recommendations workflows grouped in 27 areas:Acute Myeloid Leukemia | Acute Promyelocytic Leukemia | Breast Cancer | Cancer Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Chronic Myelomonocytic | Leukemia | Colorectal Cancer […]

Read more

IntelliseqFlow use-case

Identification of the genetic variants contributing to the early-onset semantic dementia phenotype Patient: The early-onset semantic dementia phenotype with a family history of dementia and episodic memory deficit accompanied with profound semantic loss. Problem: Due to the overlapping clinical presentations and neuropathology, clinical diagnosis of dementia is frequently challenging and inconclusive. The use of next-generation […]

Read more